Period:
Draw Mode:
| Volume | 50,196 |
|
|||||
| News | - | ||||||
| Day High | 0.9999 | Low High |
|||||
| Day Low | 0.8502 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lexaria Bioscience Corporation | LEXX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0299 | 3.08% | 0.9999 | 18:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8502 | 0.8502 | 0.9999 | 0.9999 | 0.97 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 149 | 50,196 | $ 0.9314662 | $ 46,756 | - | 0.6488 - 3.5953 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 97 | $ 0.9902 | USD |
Lexaria Bioscience Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.09M | 8.09M | - | 384k | -4.23M | 0.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lexaria Bioscience News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LEXX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.905 | 1.00 | 0.8502 | 0.9487222 | 34,891 | 0.0949 | 10.49% |
| 1 Month | 1.02 | 1.0568 | 0.844 | 0.927276 | 50,929 | -0.0201 | -1.97% |
| 3 Months | 0.72 | 1.1971 | 0.72 | 0.9132047 | 92,130 | 0.2799 | 38.88% |
| 6 Months | 2.587 | 2.78 | 0.6488 | 0.8924465 | 120,127 | -1.59 | -61.35% |
| 1 Year | 2.48 | 3.5953 | 0.6488 | 1.15 | 70,390 | -1.48 | -59.68% |
| 3 Years | 4.05 | 12.50 | 0.6488 | 5.67 | 364,492 | -3.05 | -75.31% |
| 5 Years | 4.05 | 12.50 | 0.6488 | 5.67 | 364,492 | -3.05 | -75.31% |
Lexaria Bioscience Description
| Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |